Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
Olaparib - Wikipedia
Olaparib - Wikipedia
Olaparib CAS 763113-22-0 Watson International Limited
HemOnc.org | A Hematology Oncology Wiki
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
763113-22-0 Olaparib - Watson International Ltd
Olaparib | AZD-2281 | CAS#763113-22-0 | MedKoo
Targeting dePARylation selectively suppresses DNA repair–defective and PARP inhibitor–resistant malignancies | Science Advances
Olaparib | C24H23FN4O3 | ChemSpider
Olaparib | C24H23FN4O3 | CID 23725625 - PubChem
PARP inhibitor - Wikipedia
Olaparib - Wikipedia
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
olaparib | New Drug Approvals
Supplementary appendix
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
Olaparib – Wikipedia
PharmaWiki - Olaparib
